77 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
strategy;
litigation; and
those factors discussed in the section “Risk Factors” beginning on page 4 of this prospectus.
These statements are only … and investments in other companies that may not necessarily be aligned with our current business strategy. We cannot provide any assurance that we
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
a different business strategy and began focusing on developing a portfolio of approved drugs based on cannabinoid molecules. With this focus, the Company
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect its intellectual … capabilities and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional capital
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
to the combined company’s commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect
F-1
p99rpnbs8 vwrg2oq3tj
27 Feb 24
Registration statement (foreign)
4:15pm
F-3/A
ag6zq7ngmrap5
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
e24olesa93yfafzgsf
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.2
vy1 yslikmxdket5c
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
lal6rs0nr0 m4d
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
xuhrzwpuzvt
19 Sep 23
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
6:16pm
6-K
q4rmqimuf3u5 qu
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
iai7g9fapht2xh6j1e
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
l53nvb30
10 Aug 23
Prospectus supplement
6:32am
6-K
EX-99.1
q2c5xjv6
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
6-K
2ghfe 7ntp
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
424B5
jxlfomqv
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.2
23pu s68u
29 Dec 22
Interim Consolidated Financial Statements
4:03pm